Core Viewpoint - The launch of D-allulose by COFCO Group marks a significant advancement in China's high-end functional sugar market and breaks international technological monopolies in the field of biological manufacturing [1][2]. Group 1: Product Launch and Market Impact - COFCO Group, through its subsidiaries, has introduced the first domestically produced D-allulose product, filling a gap in the high-end functional sugar market in China [1]. - D-allulose is recognized as a promising sugar substitute, with a sweetness level approximately 70% that of sucrose but only 10% of its calories, making it suitable for various food applications [1]. - The global D-allulose market is projected to reach $14.77 million in 2024, with a compound annual growth rate (CAGR) exceeding 14% from 2025 to 2034 [1]. Group 2: Industry and Health Implications - The introduction of D-allulose aligns with national public health initiatives, such as the "Weight Management Year," providing essential support for the Healthy China strategy [2]. - The product opens new innovation opportunities in low-sugar tea and baking industries, allowing consumers to enjoy healthier sweetness without compromising taste [2]. Group 3: Technological Advancements and Research - COFCO Group has invested significantly in research and development, successfully developing high-performance D-allulose-3-epimerase after extensive trials and genetic modifications [2]. - The company has established a comprehensive patent portfolio related to the biological synthesis of D-allulose, covering production strains, enzyme preparations, and separation processes, with 10 core patents already authorized [2][3]. - COFCO Group's commitment to technological innovation is reflected in its strategic initiatives, including policies that incentivize research and development as a core part of its business strategy [3].
我国高端功能糖实现自主创新突破